INNODIA BOARD
INNODIA has a board that provides strategic decision-making, guidance oversight and accountability. The board is made of one representative from each founding members, prime members, and funders; one representative from full members elected by the general assembly; and one associate from the community of people and families living with type 1 diabetes (INPACT) for a maximum of 15 board of directors.
INNODIA BOARD
INNODIA has a board that provides strategic decision-making, guidance oversight and accountability. The board is made of one representative from each founding members, prime members, and funders; one representative from full members elected by the general assembly; and one associate from the community of people and families living with type 1 diabetes (INPACT) for a maximum of 15 board of directors.
INNODIA MANAGEMENT TEAM
INNODIA is managed by a team of professionals who steer the organization, implement the organization’s strategy and translate into actions all major decisions taken by the governing board and the general assembly. Meet the team!
INNODIA MANAGEMENT TEAM
INNODIA is managed by a team of professionals who steer the organization, implement the organization’s strategy and translate into actions all major decisions taken by the governing board and the general assembly. Meet the team!
Open positions in the management team
Does this job not apply to you and yet, you're interested in working with INNODIA? Send us an open application: info@innodia.org
INNODIA GENERAL ASSEMBLY
The INNODIA general assembly is made of representatives from all members and it has the power to admit new members and approve the organisational strategies and policies. In addition to all board members, one representative from every full member has the voting rights in the general assembly (list of INNODIA full members below).
INNODIA PEOPLE and FAMILIES LIVING WITH TYPE 1 DIABETES (INPACT)
INNODIA originates from and is pointed towards people and families living with type 1 diabetes. We are based on a community of experts capable of influencing the drug-development process from research to clinical development.
"Type 1 diabetes is one of the most complex and heterogeneous diseases
and no one can solve the “Cluedo” of its pathogenesis by themselves.
Only International communities of clinicians, scientists and people with diabetes, working together, can accelerate the path to a cure.
This is why INNODIA is so crucial"!
Job opportunities
At the moment there are no job openings, but if you are interested in working with us, send us an open application: info@innodia.org